Foley Hoag Represents Organogenesis in Completed Merger with Avista Healthcare Public Acquisition Corp.

December 11, 2018

Foley Hoag LLP represented Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, in the completion of its merger with Avista Healthcare Public Acquisition Corp. (Nasdaq: AHPA), a publicly traded special purpose acquisition company. 

Affiliates of Avista Capital Partners, a leading private equity firm, have invested $92 million in the combined company in conjunction with the transaction. Organogenesis’ management team, led by Gary S. Gillheeney, Sr., will run the combined company.

Foley Hoag partners William Kolb and Stacie Aarestad and associates Ryan Rourke Reed, Remi Kathawa, Justin Beegle and Caroline Samp represented Organogenesis in the transaction.